China Nuokang Bio-Pharmaceutical Inc. Broadens Product Portfolio by Acquiring Alpha Lipoic Acid Capsule for Diabetic Patients
January 11, 2012 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Jan. 11, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a fully integrated, China-based biopharmaceutical company focused on the...
China Nuokang Bio-Pharmaceutical Inc. Announces Results of 2011 Annual General Meeting
December 23, 2011 16:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Dec. 23, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Appoints David Gao to Board of Directors
December 20, 2011 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Dec. 20, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Announces Date of Annual General Meeting
November 22, 2011 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Nov. 22, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2011 Financial Results
November 17, 2011 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
3Q11 Revenue up 3.5% YOY to RMB87.2 Million ($13.7 Million)
3Q11 Net Income was RMB7.6 Million ($1.2 Million)
9M11 Revenue was RMB231.3 Million ($36.3 Million)
9M11 Net Income was RMB32.7...
China Nuokang Bio-Pharmaceutical Inc. to Present at Cowen's China Opportunity Conference
November 07, 2011 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Nov. 7, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2011 Financial Results
November 03, 2011 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Nov. 3, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Reports Second Quarter 2011 Financial Results
August 25, 2011 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
2Q11 Revenue of RMB79.5 Million ($12.3 Million)
2Q11 Net Income of RMB14.2 Million ($2.2 Million)
Live Conference Call to be Held Friday, August 26, 2011 at 8:00 am ET
BEIJING, Aug. 25, 2011...
China Nuokang Bio-Pharmaceutical Inc. to Report Second Quarter 2011 Financial Results
August 17, 2011 09:00 ET
|
China Nuokang Bio-Pharmaceutical Inc.
BEIJING, Aug. 17, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...
China Nuokang Bio-Pharmaceutical Inc. Reports First Quarter 2011 Financial Results
May 25, 2011 16:01 ET
|
China Nuokang Bio-Pharmaceutical Inc.
1Q11 Revenue of RMB64.5 Million ($9.9 Million)
1Q11 Net Income of RMB10.9 Million ($1.7 Million)
Live Conference Call to be Held Thursday, May 26, 2011 at 8:00 am ET
BEIJING, May 25, 2011...